COVID - The Late Phase

The rate of bacterial co-infection and hospitalized patients was not 80%, like we're seeing as far as usage, but confirmed in less than 10%. So just want to point that out. Next week, tosyllismab now is approved, not just EUA, but actually has the indication for COVID. A question we often get is regarding timing of surgery after COVID. The article suggests a reduction in complications once we get to about 100 days out.